🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oppenheimer upbeat on Ingevity shares citing strong Q1 revenue and EBITDA performance

EditorEmilio Ghigini
Published 02/05/2024, 13:52
NGVT
-

On Thursday, Ingevity Corp (NYSE:NGVT) shares saw its price target increased to $58 from the previous $50, while its stock rating remained at Outperform according to Oppenheimer.

This adjustment follows Ingevity's first-quarter revenue of $340 million, surpassing both the analyst's and the consensus estimates of $309 million and $319 million, respectively. The rise in revenue was attributed to the robust performance of the Performance Materials sector.

The company's EBITDA for the first quarter stood at $77 million, which was above the anticipated $58 million by the analyst and $64 million consensus. The Performance Materials segment reported a 3% year-over-year growth, benefiting from enhanced pricing and volume increases across all regions.

This growth helped balance the repositioning within the Performance Chemicals segment and the subdued industrial demand impacting Advanced Polymer Technologies and Industrial Specialties.

Despite a 21% year-over-year decline in Performance Chemicals, attributed to exiting certain end-markets within the Industrial Specialties product line, there has been a noted improvement. Advanced Polymer Technologies experienced a 27% drop compared to the previous year but has shown sequential volume improvements over the last two quarters.

Ingevity's management has reaffirmed its full-year 2024 guidance, noting that customer order patterns continue to display caution regarding the pace of recovery in the industrial end-markets. The upgrade in the price target to $58 from $50 reflects confidence in the company's performance amid these market conditions.

InvestingPro Insights

Following the recent upgrade in Ingevity Corp's (NYSE:NGVT) price target, a look at real-time data from InvestingPro can provide further context for investors. The company's market capitalization currently stands at $1.88 billion, and while it has faced profitability challenges with a negative P/E ratio of -16.79, analysts are forecasting a turnaround with an adjusted P/E ratio for the last twelve months as of Q1 2024 at 34.85. This suggests expectations of future earnings growth, supported by a low PEG ratio of 0.11, indicating potential undervaluation relative to earnings growth.

InvestingPro Tips reveal that management at Ingevity has been actively buying back shares, which is often a sign of confidence in the company's prospects. Additionally, the company has a high shareholder yield and is expected to grow its net income this year. Over the last three months, Ingevity has demonstrated a strong return of 18.47%, and analysts predict the company will become profitable within the year.

For investors seeking more detailed analysis and additional InvestingPro Tips, there are 5 more tips available for Ingevity on InvestingPro. To access these insights and enhance your investment strategy, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.